ADLM Diagnostics Innovation and COVID Testing
In this Bio Break episode, Nick Allan and Nigel Syrotuck reflect on recent ADLM diagnostics innovation and how it has shaped the future of clinical testing. The Association for Diagnostics & Laboratory Medicine (ADLM) recently wrapped its annual showcase in Chicago, and as always, it left a strong impression on the medtech community.
While discussing highlights from the show, Nick and Nigel zero in on a perfect case study of ADLM diagnostics innovation: the evolution of COVID-19 testing. From the early days of enzyme-linked immunosorbent assays (ELISAs) to the familiar lateral flow tests we now perform at home, diagnostics have become faster, simpler, and more accessible. This transformation—from complex lab environments to point-of-care and even bathroom-counter diagnostics—was on full display at ADLM.
From the Lab to the Bathroom Counter
As Nick points out, one of the most remarkable shifts in diagnostics is how complicated procedures have been distilled into everyday routines. What once required trained technicians in controlled environments can now be done at home, often with little more than a test strip and a timer. The lateral flow transformation is a clear example of how ADLM’s influence and technology leadership help shape the direction of consumer-friendly diagnostics.
Related Resources
Lean or conventional? How to choose a medical device commercialization pathway based on funding and product market fit, and what each one costs later.
The goal of risk management in estimation is to end up in a place where the gap between estimated and actual outcomes is acceptable to stakeholders, even if it isn’t perfect.
Dr. Bill Hunter, founder and CEO of Canary Medical, joins StarFish Medical CEO Scott Phillips to unpack what it actually takes to get paid for the data an intelligent medical device generates, and why a recent shift in reimbursement could decide how fast the rest of medtech follows.
When one team designs, lays out, and brings up a board, knowledge sticks. Splitting that work across specialists looks efficient but creates the risk it’s meant to avoid.